Uniquely focussed on the practical development and applications of QSP models, the 3rd annual QSP meeting will delve deeper into the science behind the decisions in the development of these next generation models.
At this event, you will discover how leading pharmaceutical companies are applying these models to better understand disease pathogenesis and optimize pharmaceutical development. Gain unprecedented access to the data and outcomes of field defining case studies and enjoy solution led discussions.
This is a great opportunity for you to address your key challenges including integrating big data, approaches to validating these models, and current and potential methods addressing biological uncertainty and variability.
Join fellow senior scientists from both industry and academia to shape the pre-competitive culture, and build an interconnected QSP network that will become a revolutionary force in drug discovery and development.
Speakers: Birgit Schoeberl (Head of Discovery & Senior Vice President, Merrimack), Valeriu Damian-Iordache (Director - Pharmacokinetics &Translational Biology, GSK), CJ Musante (Associate Research Fellow, Pfizer Inc.), Tarek Leil (Group Dir, Head of Quantitative Clinical Pharmacology, BMS)
Category: Conferences, Science, Health and Medicine, Pharmaceuticals
1625 Post Street
San Francisco, CA
Mon Dec 5 (8:00 am - 5:00 pm)
Tue Dec 6 (8:00 am - 5:00 pm)
Wed Dec 7 (8:00 am - 5:00 pm)